U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07586124) titled 'Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma' on April 30.
Brief Summary: A multicenter, randomized, double-blind, phase II clinical study designed to evaluate the safety, pharmacokinetics, and preliminary efficacy of Becotatug Vedotin for Injection in combination with PD-1 in patients with locally advanced resectable head and neck squamous cell carcinoma
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Head and Neck Squamous Cell Carcinoma
Intervention:
DRUG: Becotatug Vedotin for Injection
Administrated intravenously
DRUG...